Report on recent microdialysis conference

Dr Mark O’Connell commented on the recent International Microdialysis Conference held in Uppsala (see, saying that he was pleased the focus is moving to improving drug therapy.  Probe Scientific has the microdialysis technology to improve the use of hospital based medication.  Mark points out that studies show that drug use is frequently sub-optimal and particular concerns have arisen over the inappropriate dosing of antibiotics and the potential to cause drug-resistance or toxicity.  Probe is already committed to an EU funded scheme using their microdialysis based technology so that transplant patients benefit from improved drug use, but the company is also planning to start microdialysis studies in London focussed on improving the use of antibiotics.’